4 months ago
CATX
AnalystsYuan ZhiYuan Zhi's Stock Forecasts
AnalystsYuan Zhi
Analyst Ranking
Top 8%
#405 out of 5337 analysts
Average Return
+33.31%
Win Rate
44%18 out of 41
Risk vs Reward
Poor
Good
Yuan Zhi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +554.97% | $3.22 | $21.09 | 2023-10-03 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +446.37% | $3.86 | $21.09 | 2023-03-30 - 2024-03-20 | Strong Buy |
Tango Therapeutics IncTNGX | +233.13% | $8.00 | $26.65 | 2025-11-18 - 2026-07-28 | Strong Buy |
Hyperfine IncHYPR | +166.67% | $0.60 | $1.60 | 2025-05-15 - 2026-05-14 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +141.92% | $2.29 | $5.54 | 2022-12-01 - 2023-11-30 | Strong Buy |
Yuan Zhi Analyst Color
Get additional color on Yuan Zhi's coverage of popular stocks
5 months ago
TOI
7 months ago
RADX
8 months ago
RDNT
8 months ago
TNGX
a year ago
MIR
a year ago
CATX
2 years ago
CATX
2 years ago
AZTA
Yuan Zhi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lyell Immunopharma IncLYEL | 1 | Strong Buy | $44.00 | +238.72% | Initiates Coverage On | 8 days ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $10.00 | +171.74% | Initiates Coverage On | a month ago |
Strata Critical Medical IncSRTA | 1 | Strong Buy | $8.00 | +57.17% | Initiates Coverage On | 4 months ago |
Perspective Therapeutics IncCATX | 5 | Strong Buy | $13.00 | +352.96% | Maintains | 4 months ago |
Oncology Institute IncTOI | 2 | Strong Buy | $8.00 | +61.62% | Maintains | 5 months ago |
Radiopharm Theranostics LtdRADX | 3 | Strong Buy | $16.00 | +383.38% | Reiterates | 7 months ago |
Radnet IncRDNT | 2 | Strong Buy | $87.00 | +37.61% | Maintains | 8 months ago |
Tango Therapeutics IncTNGX | 3 | Strong Buy | $14.00 | -47.47% | Maintains | 8 months ago |
Mirion Technologies IncMIR | 3 | Strong Buy | $22.00 | N/A | Reiterates | a year ago |
Hyperfine IncHYPR | 2 | Strong Buy | $1.00 | N/A | Maintains | a year ago |
Agenus IncAGEN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Cryoport IncCYRX | 4 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Cytosorbents CorpCTSO | 1 | Strong Buy | $3.00 | N/A | Reiterates | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Azenta IncAZTA | 3 | Strong Buy | $79.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 2 | Hold | $28.00 | N/A | Downgrades | 3 years ago |
Actinium Pharmaceuticals IncATNM | 4 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Iveric Bio IncISEE | 3 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.